Preliminary scientific tests suggest conolidine may inhibit specific ion channels, decreasing neuronal excitability and restricting discomfort signals. This system is especially suitable in neuropathic soreness, in which irregular signaling will cause persistent distress. Also, conolidine appears to influence G protein-coupled receptor (GPCR) pathways integral to agony notion. Computa... https://henryz714gby4.wikilowdown.com/user